Research Article: Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis
Introduction:
Recently, samidorphan (SAM) has received much attention as a novel formulation for reducing olanzapine’s (OLZ) side effects in schizophrenia (SCZ) treatment. – Despite the widespread recognition of OLZ’s efficacy in treating SCZ, its concomitant significant safety concerns of weight gain and associated metabolic disorders (eg, hyperglycemia, hypercholesterolemia, hyperlipidemia) continue to be a primary factor limiting its widespread clinical use. , , Numerous investigations have determined that OLZ has fewer…
Read more